Peripheral Vascular Devices size is expected to be worth around USD 24.9 Bn by 2032 from USD 15.2 Bn in 2022, growing at a CAGR of 5.2% during the forecast period from 2023 to 2032.
Overview of Peripheral Vascular Devices:
Peripheral vascular devices are medical devices used to diagnose and treat disorders related to the circulatory system outside of the heart and brain, specifically disorders affecting extremities like legs and arms. Peripheral vascular diseases encompass an array of conditions like peripheral artery disease (PAD), deep vein thrombosis (DVT), and varicose veins; peripheral vascular devices play an integral part in managing these conditions by increasing blood flow, decreasing pain levels, and avoiding potential complications.
Key Market Segments
By Type Analysis
- Peripheral Stents
- PTA Balloons
- Catheters
- Peripheral Accessories
By End-User Analysis
- Hospital
- Ambulatory surgical centers
- specialty clinics
Regional Analysis:
North America's peripheral vascular devices industry is driven by high prevalence rates for lifestyle-related illnesses, advanced healthcare infrastructure, and favorable reimbursement policies; Europe is driven by an aging population and rising awareness about minimally invasive treatments; Asia-Pacific offers immense growth potential thanks to rising healthcare expenditure, improving facilities and large patient numbers; Latin America and Middle East industry are gradually growing due to improved access and growing awareness regarding the peripheral vascular disease.
Top Key Players in the Peripheral Vascular Devices
- Abbott Laboratories
- Angioscore Inc.
- Edward Lifesciences Corporation
- Medtronic Inc.
- Jude Medical
- Teleflex Medical
- Volcano Corporation
- Boston Scientific Corporation
- Teleflex Medical
- Cook Group Inc.
- Cordis Corporation
- Covidien
